[HTML][HTML] Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour …

V Minard-Colin, JL Ichante, L Nguyen, A Paci… - European Journal of …, 2012 - Elsevier
AIM: This phase II study evaluated efficacy, safety and pharmacokinetics (PK) profile of
combination intravenous vinorelbine (VNL) and continuous low doses oral …

Robotic compounding versus manual compounding of chemotherapy: comparing dosing accuracy and precision

TH Geersing, MG Klous, EJF Franssen… - European Journal of …, 2020 - Elsevier
Background Cytostatic drugs are increasingly being prepared with a cytostatic robot, though
it is not known whether the dose of the final product is more accurate after automated or …

A UV-Raman spectrometry method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy

F Nardella, M Beck, P Collart-Dutilleul, G Becker… - International journal of …, 2016 - Elsevier
In France, chemotherapy preparation units of hospital pharmacy compound cytotoxic
infusion bags adapted to each patient. The narrow therapeutic index of these preparations …

SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update

J Vigneron, A Astier, R Trittler, JD Hecq… - Annales …, 2013 - Elsevier
The recommandations for the practical stability of anticancer drugs published in 2010 by the
French Society of Hospital Pharmacists (SFPO) and the European Society of Oncology …

Stability of cyclophosphamide in extemporaneous oral suspensions

R Kennedy, D Groepper, M Tagen… - Annals of …, 2010 - journals.sagepub.com
Background: Cyclophosphamide, an alkylating agent, is widely used for the treatment of
many adult and pediatric malignancies. The stability of cyclophosphamide in aqueous-and …

Stability of antineoplastic agents in use for home-based intravenous chemotherapy

F Benizri, B Bonan, AL Ferrio, ML Brandely… - Pharmacy world & …, 2009 - Springer
Aim of the review The aim of this work was first to define which antineoplastic agents with
sufficiently long stability could be eligible in the circuit of home-based therapy (centralised …

FabAct®: a decision‐making tool for the anticipation of the preparation of anticancer drugs

B Bonan, N Martelli, M Berhoune… - Journal of evaluation …, 2010 - Wiley Online Library
Rationale Due to the increase of new cancer cases, our chemotherapy compounding unit
must face with ever‐growing production needs. To support this increasing workload, we …

[PDF][PDF] The practical stability of anticancer drugs: SFPO and ESOP recommendations

A Astier, F Pinguet, J Vigneron - European Journal of Oncology …, 2010 - sfpo.com
It is critical for hospital pharmacists to have well-documented data about the real stability of
an opened drug formulation, after reconstitution of a lyophilised product or after dilution in …

Arsenate and dimethylarsinic acid in drinking water did not affect DNA damage repair in urinary bladder transitional cells or micronuclei in bone marrow

A Wang, AD Kligerman, SD Holladay… - Environmental and …, 2009 - Wiley Online Library
Arsenic is a human skin, lung, and urinary bladder carcinogen, and may act as a
cocarcinogen in the skin and urinary bladder. Possible modes of action of arsenic …

A literature review of reports of the stability and storage of common injectable chemotherapy agents used in veterinary patients

CM Chan, AE Frimberger… - … and comparative oncology, 2017 - Wiley Online Library
Many chemotherapy drugs used in human patients are discarded after single use or within
24 h of reconstitution, as per the manufacturer's product label recommendations. This can be …